---
title: "LINTON DOUGLAS — Ownership Dossier"
canonical: https://whiteintel.dev/entity/f97fd20e-e22f-55e3-a0f4-4fa03fd2d373
json: https://whiteintel.dev/api/public/dossier/f97fd20e-e22f-55e3-a0f4-4fa03fd2d373
identifier: sec:0001379819
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# LINTON DOUGLAS

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001379819`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/f97fd20e-e22f-55e3-a0f4-4fa03fd2d373  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/f97fd20e-e22f-55e3-a0f4-4fa03fd2d373  

## Ownership & control

### Holdings / subsidiaries

- **BRADLEY PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/4f0533c1-1ba6-5ba8-97c5-464f009b9413

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **LINTON DOUGLAS**. Human view: https://whiteintel.dev/entity/f97fd20e-e22f-55e3-a0f4-4fa03fd2d373 · Structured JSON: https://whiteintel.dev/api/public/dossier/f97fd20e-e22f-55e3-a0f4-4fa03fd2d373._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._